
Bain Capital-backed medical technology firm Heartflow's HTFL.O shares indicated to open above offer price in Nasdaq debut
Stock indicated to open at $25 vs $19 IPO price
HTFL late Thursday sold 16.7 million shares above the marketed range of $17 and $18 apiece for gross proceeds of $316.7 million in an upsized IPO
Mountain View, California-based HTFL upsized its offering and raised the proposed range earlier this week reflecting strong demand
HTFL marks the third sizable medtech listing in New York in less than a month
Founded in 2007 as Cardiovascular Simulation, Heartflow's AI-enabled products help physicians to diagnose and treat heart disease
J.P. Morgan, Morgan Stanley and Piper Sandler were the lead underwriters for the offering